Autres langues Forte Biosciences, Inc.

Actions

FBRX

US34962G2084

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/07/2026			Varia. 5j.	Varia. 1 janv.
76,60 ^USD	-0,49%		+39,83%	+180,89%

28/07	RÉSULTATS ET ACTIVITÉ : Allergy Therapeutics nomme son prochain président exécutif	AN
27/07	Les plus fortes hausses de la mi-séance	MT

Autres langues

28/07	Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
28/07	EARNINGS AND TRADING: Allergy Therapeutics names next executive chair
27/07	Health Care Up Amid Deal Activity -- Health Care Roundup
27/07	Aktien New York Schluss: Chip-Sorgen bremsen Ölpreiserleichterung
27/07	Aktien New York: Ölpreiseuphorie schwindet wegen Chipsektor-Sorgen
27/07	Top Midday Gainers
27/07	US Equity Indexes Mixed as Tech Heads Lower, Crude Oil Sinks on Pause in Iran Strikes
27/07	Astrazeneca Rises on Profit Beat; Paramount Pauses WBD Deal \| Stock Movers
27/07	Aktien New York: Dow profitiert von Ölpreisen - Nasdaq unter Druck
27/07	Global markets live: Nvidia, Coca-Cola, Rocket Lab, KKR, OpenAI…
27/07	Stocks Rise Pre-Bell as US, Iran Pause Strikes; Fed Policy Decision, Inflation Report on Deck
27/07	Top Premarket Gainers
27/07	Forte Biosciences Agrees to Be Acquired by Argenx in $2.2 Billion Deal
27/07	Forte Biosciences Shares Leap Premarket on Takeover by Argenx
27/07	Deals of the day-Mergers and acquisitions
27/07	European Midday Briefing : Stocks Gain as Further Iran Attacks Paused
27/07	Argenx to Acquire Forte Biosciences for $2.2 Billion
27/07	Argenx to Acquire Forte Biosciences for $2.2 Billion
27/07	Argenx SE entered into a definitive agreement to acquire Forte Biosciences, Inc. for $1.6 billion.
27/07	PRESS DIGEST-Wall Street Journal - July 27
27/07	Argenx kauft Forte Biosciences - Erweiterung der Immunologie-Pipeline
27/07	Argenx to Buy Forte Biosciences for $2.2 Billion
27/07	Argenx to Buy Forte Biosciences Under $2.2 Billion Deal
27/07	Argenx to buy Forte Biosciences for about $2.2 billion
10/07	Forte Biosciences, Inc. - FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 after Completion of 12-Week Treatment Period